Influence of GNRH agonist in luteal phase support for assisted reproductive techniques
Design
clinical trial with two parallel arm non randomized 100 patient group
Settings and conduct
20-39 years old infertile normal responder patients candidate for IVF,divide to two non randomized parallel group,in case group we inject 0.1mg triptorlin in days 0-3-6 plus 400 mg intravaginal cyclogest twice daily.in control group we just prescribe 400 mg intra vaginal cyclogest twice daily for luteal phase support.
2 weeks after tansfering serum BHCG will check and 2 weeks after positive BHCG,vaginal sonography for checking gestatioal sac and fetal heart rate will be done.
Infertile women with normal ovarian response that subcutaneus inject of triptorelin 0/1 mg 0-3-6 days after fresh transfer
Main outcome variables
Chemical pregnancy-clinical pregnancy
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20110509006420N20
Registration date:2020-03-11, 1398/12/21
Registration timing:registered_while_recruiting
Last update:2020-03-11, 1398/12/21
Update count:3
Registration date
2020-03-11, 1398/12/21
Registrant information
Name
Maryam Eftekhar
Name of organization / entity
Yazd Research and Clinical Center for Infertility
Country
Iran (Islamic Republic of)
Phone
+98 35182470856
Email address
eftekhar@ssu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-09-23, 1398/07/01
Expected recruitment end date
2020-04-19, 1399/01/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effects of GnRH agonist for luteal phase support in assisted reproductive cycles
Public title
Effects of GnRH agonist for luteal phase support
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
age 20-39 years
fresh embryo transfer cycles
Exclusion criteria:
absence of good quality embryo
ovarian hyper stimulation (more than 18 mature follicle during ovarian stimulation)
severe male factor
low ovarian response
Age
From 20 years old to 39 years old
Gender
Female
Phase
3
Groups that have been masked
No information
Sample size
Target sample size:
200
Randomization (investigator's opinion)
Not randomized
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Yazd Research and Clinical Center for infertility, Shahid Sadoughi University of
Street address
Bouali Ave, Safaeiyeh
City
Yazd
Province
Yazd
Postal code
8916877391
Approval date
2019-12-29, 1398/10/08
Ethics committee reference number
IR.SSU.RSI.REC.1398.043
Health conditions studied
1
Description of health condition studied
female infertility
ICD-10 code
N97
ICD-10 code description
Female infertility
Primary outcomes
1
Description
Chemical pregnancy
Timepoint
2 weeks after embryo transfer
Method of measurement
serum BHCG
2
Description
clinical pregnancy
Timepoint
6 weeks after embryo transfer
Method of measurement
sonography
Secondary outcomes
empty
Intervention groups
1
Description
taking 0/1 mg triptorelin in 0-3-6 days after fresh emeryo transfer plus 400mg vaginal cyclogest twice daily for luteal phase support.
Category
Treatment - Drugs
2
Description
Control group: taking 400mg vaginal cyclogest twice daily for luteal phase support.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Yazd Research and Clinical Center for Infertility
Full name of responsible person
Dr. Maryam Eftekhar
Street address
Boali Ave., Safayeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 3824 7085
Email
info@yazd-rsi.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Vice Chancellor for research of Shahid Sadoughi University of Medical Sciences
Full name of responsible person
Dr.Maryam Eftekhar
Street address
Research and Clinical Center for Infertility, Bouali, Timsar Fallahy, Safayeh, Yazd
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 3824 7085
Email
info@yazd-rsi-ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Yazd University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Yazd University of Medical Sciences
Full name of responsible person
Maryam Eftekhar
Position
professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Bouali Ave, Safaeyeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35182470856
Fax
+98 35 1824 7087
Email
eftekhar@ssu.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Yazd University of Medical Sciences
Full name of responsible person
Maryam Eftekhar
Position
professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Bouali Ave, Safaeyeh
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35182470856
Fax
+98 35 1824 7087
Email
eftekhar@ssu.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Yazd University of Medical Sciences
Full name of responsible person
Maryam Mirzaei
Position
fellowship
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Research and Clinical Center for Infertility, Bouali, Timsar Fallahy, Safayeh, Yazd
City
Yazd
Province
Yazd
Postal code
8916877391
Phone
+98 35 3824 7085
Email
maryammirzaei@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available